Skip to main content

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology. A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the new programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

Logo of Novo Nordisk (University of Oxford).

Similar stories

DPhil sponsorship agreement with medical university and hospital /medical centre in Taiwan

On 28 August, RDM signed a Memorandum of Understanding with the National Defense Medical University and Tri-Service General Hospital in Taiwan which will provide funding for their students who have successfully enrolled on the DPhil in Medical Sciences.